aggrecan fragments (R&D Systems)
Structured Review

Aggrecan Fragments, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 42 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aggrecan+fragments/Human+Aggrecan+G1-IGD-G2+Domains+Antibody/pmc12999771-100-28-32
Average 93 stars, based on 42 article reviews
Images
1) Product Images from "Targeting EFEMP1 enhances chondrogenesis and inhibits hypertrophic differentiation in a spontaneous osteoarthritis mouse model"
Article Title: Targeting EFEMP1 enhances chondrogenesis and inhibits hypertrophic differentiation in a spontaneous osteoarthritis mouse model
Journal: Journal of Molecular Medicine (Berlin, Germany)
doi: 10.1007/s00109-026-02656-y
Figure Legend Snippet: Effect of EFEMP1 knockdown by small interfering RNA (siRNA) on chondrocyte phenotype. A The human chondrocyte cell line C20A4 was transfected with either EFEMP1 siRNA (siEFEMP1) or scrambled siRNA (siCtrl). EFEMP1 and MMP-13 protein expression was analyzed by Western blotting. B Chondrocyte-related gene expression, including SOX9, aggrecan (ACAN), MMP13, type X collagen (COL10A1), and type II collagen (COL2A1), was assessed by quantitative PCR in siEFEMP1- and siCtrl-treated C20A4 cells. C Phosphokinase protein arrays were used to profile phosphorylation changes in intracellular proteins extracted from C20A4 chondrocytes. D Spot intensities exhibiting changes greater than ± 25% between groups were quantified using ImageJ software. Red lines indicate baseline levels from the siCtrl group. E Phosphorylation of p70S6K at threonine 421/serine 424 (T421/T424) was further examined by Western blot analysis. Data are presented as mean ± standard error of the mean (SEM). Statistical significance was determined using an independent-samples t-test. * P < 0.05, ** P < 0.01, and *** P < 0.001
Techniques Used: Knockdown, Small Interfering RNA, Transfection, Expressing, Western Blot, Gene Expression, Real-time Polymerase Chain Reaction, Phospho-proteomics, Software
Figure Legend Snippet: Immunofluorescence analysis of cartilage markers following EFEMP1 antibody treatment in STR/ort mice. A Representative immunofluorescence (IF) staining for EFEMP1, SOX9, MMP13, aggrecan fragments, COL2A1, and COL10A1 in the medial femoral condyle (MF) and medial tibial plateau (MT). Nuclei were counterstained with DAPI (blue), and articular cartilage regions are outlined by orange dashed lines. B Quantification of fluorescence intensity in articular cartilage regions of the femoral condyle and tibial plateau, with medial and lateral compartments combined. EFEMP1 and SOX9 signals were normalized to DAPI, whereas MMP13, aggrecan fragments, COL10A1, and COL2A1 signals were quantified as absolute FITC intensity. Data are presented as mean ± standard error of the mean (SEM). Statistical analysis was performed using an independent-samples t -test. P < 0.05, P < 0.01, and ** P < 0.001
Techniques Used: Immunofluorescence, Staining, Fluorescence
Related Articles
Staining:Article Title: Characterization and Advancement of an Evaluation Method for the Treatment of Spontaneous Osteoarthritis in STR/ort Mice: GRGDS Peptides as a Potential Treatment for Osteoarthritis. Article Snippet: .. Subsequently, 5 μm thick sections were stained with (1) safranin O, (2) Article Title: Therapeutic blockade of platelet-derived growth factor receptor-like protein attenuates cartilage degeneration and modulates cytokines in a spontaneous osteoarthritis mouse model. Article Snippet: .. Subsequently, they were stained with the following antibodies: PDGFRL (1:50, 16217–1-AP, Protentech, Chicago, IL, USA), Article Title: The role of EDIL3 in maintaining cartilage extracellular matrix and inhibiting osteoarthritis development Article Snippet: .. The 5 μm-thick sections were stained with: 1) Safranin O; 2) Article Title: Timing of intra-articular injection of adipose-derived mesenchymal stem cells affects cartilage integrity and IL-18 expression in spontaneous osteoarthritis: A preclinical study. Article Snippet: Osteoarthritis (OA) is a progressive joint disease primarily characterized by cartilage degradation.. A phase I/II clinical trial demonstrated the therapeutic efficacy of a human adipose-derived mesenchymal stem cell (ADMSC) product in patients with knee OA.. However, it remains unclear whether its efficacy varies with disease stage or whether a single intra-articular dose offers sustained protection. Incubation:Article Title: Targeting EFEMP1 enhances chondrogenesis and inhibits hypertrophic differentiation in a spontaneous osteoarthritis mouse model Article Snippet: For IF staining, Dako Antibody Diluent (Cat. No. S3022, Agilent Dako, Denmark) was used as the blocking buffer for 60 min at 25 °C. .. Samples were incubated overnight at 4 °C with primary antibodies against EFEMP1 (1:100, NBP1-77040; NOVUS, USA), SOX9 (1:50, sc-166505; Santa Cruz Biotechnology, USA), MMP-13 (1:100, GTX100665; GeneTex, USA), Article Title: Timing of intra-articular injection of adipose-derived mesenchymal stem cells affects cartilage integrity and IL-18 expression in spontaneous osteoarthritis: A preclinical study. Article Snippet: Osteoarthritis (OA) is a progressive joint disease primarily characterized by cartilage degradation.. A phase I/II clinical trial demonstrated the therapeutic efficacy of a human adipose-derived mesenchymal stem cell (ADMSC) product in patients with knee OA.. However, it remains unclear whether its efficacy varies with disease stage or whether a single intra-articular dose offers sustained protection. Immunofluorescence:Article Title: Timing of intra-articular injection of adipose-derived mesenchymal stem cells affects cartilage integrity and IL-18 expression in spontaneous osteoarthritis: A preclinical study. Article Snippet: Osteoarthritis (OA) is a progressive joint disease primarily characterized by cartilage degradation.. A phase I/II clinical trial demonstrated the therapeutic efficacy of a human adipose-derived mesenchymal stem cell (ADMSC) product in patients with knee OA.. However, it remains unclear whether its efficacy varies with disease stage or whether a single intra-articular dose offers sustained protection. |
